OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.41 | Prev. Close $0.40 | Circuit Range N/A |
Day Range $0.41 - $0.42 | Year Range $0.38 - $1.79 | Volume 4,217 |
Average Traded $0.42 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $0.41 | $0.42 | +0.00% |
10-Jun-26 | $0.41 | $0.42 | +5.26% |
09-Jun-26 | $0.41 | $0.40 | +0.76% |
08-Jun-26 | $0.38 | $0.40 | +2.06% |
05-Jun-26 | $0.41 | $0.39 | -7.62% |
04-Jun-26 | $0.42 | $0.42 | -0.94% |
03-Jun-26 | $0.40 | $0.42 | +3.67% |